PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 78 filers reported holding PLIANT THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $7,479,627 | -31.2% | 281,189 | -50.0% | 0.79% | -41.7% |
| Q4 2022 | $10,870,786 | -7.5% | 562,379 | 0.0% | 1.35% | -7.8% |
| Q3 2022 | $11,748,000 | +160.8% | 562,379 | 0.0% | 1.46% | +180.1% |
| Q2 2022 | $4,505,000 | +14.3% | 562,379 | 0.0% | 0.52% | +31.2% |
| Q1 2022 | $3,942,000 | -48.1% | 562,379 | 0.0% | 0.40% | -44.2% |
| Q4 2021 | $7,592,000 | -20.0% | 562,379 | 0.0% | 0.71% | +28.2% |
| Q3 2021 | $9,493,000 | -42.0% | 562,379 | 0.0% | 0.56% | -41.0% |
| Q2 2021 | $16,376,000 | -26.0% | 562,379 | 0.0% | 0.94% | -23.8% |
| Q1 2021 | $22,118,000 | +73.1% | 562,379 | 0.0% | 1.24% | +78.4% |
| Q4 2020 | $12,777,000 | +0.3% | 562,379 | 0.0% | 0.69% | -1.0% |
| Q3 2020 | $12,738,000 | -30.2% | 562,379 | 0.0% | 0.70% | -55.0% |
| Q2 2020 | $18,255,000 | – | 562,379 | – | 1.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 339,160 | $5,881,034 | 100.00% |
| CHI Advisors LLC | 3,014,199 | $52,266,211 | 20.72% |
| TRV GP IV, LLC | 2,132,867 | $36,983,914 | 13.93% |
| GREAT POINT PARTNERS LLC | 1,755,184 | $30,434,891 | 5.54% |
| First Light Asset Management, LLC | 2,933,260 | $50,862,728 | 4.83% |
| Deep Track Capital, LP | 5,500,000 | $95,370,000 | 3.68% |
| Casdin Capital, LLC | 1,577,108 | $27,347,053 | 3.03% |
| Fernwood Investment Management, LLC | 379,702 | $6,584,033 | 2.37% |
| Redmile Group, LLC | 2,678,099 | $46,438,237 | 2.21% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 250,409 | $4,342,092 | 1.32% |